(Q38163820)

30 August 2017

title

Bringing rigour to translational medicine (English)

1 reference

30 August 2017

3

1 reference

30 August 2017

Emily S Sena

2

0 references

David Howells

object named as

David W Howells

series ordinal

1

0 references

language of work or name

English

0 references

publication date

19 November 2013

1 reference

30 August 2017

published in

Nature Reviews Neurology

1 reference

30 August 2017

volume

10

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

37-43

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2013.232

30 August 2017

exact match

0 references

cites work

The burden of brain diseases in Europe

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

The economic cost of brain disorders in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Recent developments in Alzheimer's disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Effect of the new diagnostic criteria for ST-elevation and non-ST-elevation acute myocardial infarction on 4-year hospitalization: an analysis of hospital discharge records in the Veneto Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Preventing stroke: saving lives around the world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

How to make better use of thrombolytic therapy in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Fresh from the biologic pipeline—2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

The cost of drug development: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Recommendations for clinical trial evaluation of acute stroke therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Update of the stroke therapy academic industry roundtable preclinical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

1,026 experimental treatments in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Pooling of animal experimental data reveals influence of study design and publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

A systematic review and meta-analysis of erythropoietin in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

An enriched environment improves sensorimotor function post-ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Replication and reproducibility in spinal cord injury research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Design, power, and interpretation of studies in the standard murine model of ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Publication bias in reports of animal stroke studies leads to major overstatement of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Differences in the evolution of the ischemic penumbra in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Impact of genetic and renovascular chronic arterial hypertension on the acute spatiotemporal evolution of the ischemic penumbra: a sequential study with MRI in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Improving the translational hit of experimental treatments in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Hypertension and experimental stroke therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Inducing stroke in aged, hypertensive, diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Isoflurane anesthesia induced persistent, progressive memory impairment, caused a loss of neural stem cells, and reduced neurogenesis in young, but not adult, rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Evaluation of excess significance bias in animal studies of neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Avoidable waste in the production and reporting of research evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Improving the efficiency of the development of drugs for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Replication validity of genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

REPRINT: International, multicenter randomized preclinical trials in translational stroke research: it is time to act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

International, multicenter randomized preclinical trials in translational stroke research: it's time to act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Detecting fabrication of data in a multicenter collaborative animal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Good laboratory practice: preventing introduction of bias at the bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Reprint: Good laboratory practice: preventing introduction of bias at the bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Reprint: Good laboratory practice: preventing introduction of bias at the bench.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

A call for transparent reporting to optimize the predictive value of preclinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Announcement: Reducing our irreproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Enhancing the Development and Approval of Acute Stroke Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.232

The Blood and Bone Marrow in Yelloe Cross Gas (Mustard Gas) Poisoning: Changes produced in the Bone Marrow of Fatal Cases

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24247324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24247324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2013.232

1 reference

Dimensions Publication ID

30 August 2017

1046334829

0 references

1 reference